Kerala issues revised norms for international air passengers

As per the new guidelines, all the international passengers, irrespective of their duration of stay in Kerala, need to undergo self- symptom surveillance and if found symptomatic undertake an RT-PCR test.

PTI

February 05, 2022 / 19:51 IST

Representative image: AP

The Health Department of Kerala on Saturday issued revised guidelines for international air passengers arriving in Kerala. As per the new guidelines, all the international passengers, irrespective of their duration of stay in Kerala, need to undergo self- symptom surveillance and if found symptomatic undertake an RT-PCR test.

The guidelines were issued based on the recommendations of an expert panel, said State Health Minister Veena George in a press release. "Random testing of two per cent of international travellers by flight irrespective of the country of departure to be done free of cost (state government to bear the cost) and the selection of the passengers is to be done by the airline officers," the guidelines said.

ALSO READ: WHO chief Tedros Adhanom Ghebreyesus says world at 'critical juncture' in COVID pandemic

The Minister said in order to mitigate the third wave of the pandemic, the State Health Department strengthened the eSanjeevani system, a portal, to deliver healthcare service to people on a tele-medicine platform. The eSanjeevani has now more doctors, she said.

"In the COVID OP which has been functioning round the clock, there will be 15 to 20 doctors during the day and four doctors at night. The normal waiting period is one minute and if it increases, more doctors will be added to the system," the Minister said in the release. Last month, over 18,000 people used the service of the portal and there was an 800 per cent increase when compared with previous months, she said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show